Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
National Institutes of Health · Cancer Detection and Diagnosis Research (93.394)
Posted 3 Jun 2026 · 40 days left
In plain terms
The U.S. National Cancer Institute funds early-stage development of innovative technologies for cancer research, including new molecular and cellular characterization methods and biospecimen handling tools. Grants up to 150,000 US dollars support proof-of-concept projects from universities, nonprofits, small businesses, and government agencies worldwide, with applications due by 10 November 2026.
A generated summary of the donor's text; the original wording is below.
Summary
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits grant applications proposing to develop innovative technologies offering new capabilities for the molecular or cellular characterization of cancer or for improved handling and quality control of biospecimens for basic, clinical, or epidemiological cancer research. The NOFO solicits R61 applications for early-stage projects proposing proof-of-concept/pilot studies to test the technical feasibility of the proposed method, tool, assay, platform, or instrument. Technologies proposed for development may have potential for widespread applicability but must be focused for this program on cancer-relevant use cases. Projects proposing to apply or use existing technologies for hypothesis-driven research where the novelty resides in the biological or clinical target/question being pursued are not responsive to this solicitation and will not be reviewed.This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program.
Excerpt from the donor's page. The full text, annexes and forms are on the original call.
Eligible regions
- global
Who can apply
- academia_research
- ngo_cso
- private_company
- government
- community_based_org
Eligibility and conditions
Show the eligibility text from the source
Applicant types: Native American tribal organizations (other than Federally recognized tribal governments); Public and State controlled institutions of higher education; Independent school districts; Small businesses; Public housing authorities/Indian housing authorities; City or township governments; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Native American tribal governments (Federally recognized); Private institutions of higher education; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; For profit organizations other than small businesses; Others (see text field entitled "Additional Information on Eligibility" for clarification); County governments; State governments; Special district governments
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.